Drug factory · FDA FEI 3008592343
Narodowe Centrum Badan Jadrowych
Ul. Andrzeja Soltana 7, Otwock, Poland
Problems found, fixed voluntarily at FDA's last inspection, May 24, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2010: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Strontium Cation SR-89 | Makes the active ingredient | Q BioMed Inc | 72928-089 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| May 24, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Sep 16, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.